rss
Br J Ophthalmol 2004;88:306-307 doi:10.1136/bjo.2003.021956
  • Letter

Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension

  1. C S Marsh,
  2. B Marden,
  3. R Newsom
  1. Southampton Eye Unit, Southampton, UK
  1. Correspondence to: Catherine Marsh Southampton Eye Unit, Southampton, UK; cathmarshdoctors.org.uk
  • Accepted 28 April 2003

Sildenafil is used as a selective pulmonary vasodilator in children with primary pulmonary hypertension and severe lung fibrosis.1 It improves gas exchange, increasing life expectancy and exercise tolerance. Recent animal models of neonatal pulmonary hypertension have also shown that sildenafil reduces vascular resistance. This has encouraged its use in units treating premature infants.2 We report a case of severe retinopathy of prematurity in a preterm infant who was treated with intravenous sildenafil for severe respiratory failure.

Case report

The patient was born at 26 weeks gestation weighing 525 g. He was ventilated from birth for respiratory insufficiency, secondary to respiratory distress syndrome. He required high flow oxygen ventilation and received surfactant at delivery and 16 hours later. His oxygen requirements then stabilised at 30–50%.

At 29 weeks …

Responses to this article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.